A detailed history of Jacobson & Schmitt Advisors, LLC transactions in Danaher Corp stock. As of the latest transaction made, Jacobson & Schmitt Advisors, LLC holds 80,502 shares of DHR stock, worth $18.2 Million. This represents 4.6% of its overall portfolio holdings.

Number of Shares
80,502
Previous 78,936 1.98%
Holding current value
$18.2 Million
Previous $19.7 Million 13.47%
% of portfolio
4.6%
Previous 4.48%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$239.25 - $280.76 $374,665 - $439,670
1,566 Added 1.98%
80,502 $22.4 Million
Q2 2024

Aug 12, 2024

BUY
$235.51 - $267.98 $948,398 - $1.08 Million
4,027 Added 5.38%
78,936 $19.7 Million
Q1 2024

May 08, 2024

SELL
$224.58 - $256.19 $3,817 - $4,355
-17 Reduced 0.02%
74,909 $18.7 Million
Q4 2023

Feb 08, 2024

BUY
$185.1 - $233.13 $1.5 Million - $1.88 Million
8,081 Added 12.09%
74,926 $17.3 Million
Q3 2023

Nov 07, 2023

BUY
$233.08 - $265.59 $249,162 - $283,915
1,069 Added 1.63%
66,845 $16.6 Million
Q2 2023

Aug 14, 2023

BUY
$224.99 - $256.14 $3.1 Million - $3.53 Million
13,775 Added 26.49%
65,776 $15.8 Million
Q1 2023

May 12, 2023

SELL
$239.75 - $277.0 $2.28 Million - $2.63 Million
-9,504 Reduced 15.45%
52,001 $13.1 Million
Q3 2022

Nov 09, 2022

BUY
$247.06 - $1507.4 $286,589 - $1.75 Million
1,160 Added 1.92%
61,505 $15.9 Million
Q2 2022

Aug 08, 2022

BUY
$237.11 - $299.66 $251,573 - $317,939
1,061 Added 1.79%
60,345 $15.3 Million
Q1 2022

May 06, 2022

BUY
$257.27 - $315.76 $2.04 Million - $2.5 Million
7,932 Added 15.45%
59,284 $17.4 Million
Q4 2021

Feb 10, 2022

BUY
$292.08 - $329.01 $679,086 - $764,948
2,325 Added 4.74%
51,352 $16.9 Million
Q3 2021

Nov 12, 2021

SELL
$272.21 - $332.43 $113,239 - $138,290
-416 Reduced 0.84%
49,027 $14.9 Million
Q2 2021

Aug 10, 2021

SELL
$225.08 - $271.69 $222,829 - $268,973
-990 Reduced 1.96%
49,443 $13.3 Million
Q1 2021

May 11, 2021

SELL
$212.38 - $245.9 $899,641 - $1.04 Million
-4,236 Reduced 7.75%
50,433 $11.4 Million
Q4 2020

Feb 11, 2021

SELL
$212.5 - $245.46 $92,012 - $106,284
-433 Reduced 0.79%
54,669 $12.1 Million
Q3 2020

Nov 04, 2020

SELL
$177.16 - $215.33 $482,761 - $586,774
-2,725 Reduced 4.71%
55,102 $11.9 Million
Q2 2020

Aug 13, 2020

BUY
$128.7 - $176.83 $80,051 - $109,988
622 Added 1.09%
57,827 $10.2 Million
Q1 2020

May 11, 2020

SELL
$121.39 - $169.05 $276,890 - $385,603
-2,281 Reduced 3.83%
57,205 $7.92 Million
Q4 2019

Feb 10, 2020

SELL
$133.47 - $153.48 $50,184 - $57,708
-376 Reduced 0.63%
59,486 $9.13 Million
Q3 2019

Nov 12, 2019

SELL
$135.4 - $146.47 $154,626 - $167,268
-1,142 Reduced 1.87%
59,862 $8.65 Million
Q2 2019

Aug 05, 2019

BUY
$124.88 - $143.73 $151,604 - $174,488
1,214 Added 2.03%
61,004 $8.72 Million
Q1 2019

May 15, 2019

BUY
$97.62 - $132.29 $289,443 - $392,239
2,965 Added 5.22%
59,790 $7.89 Million
Q1 2019

May 02, 2019

SELL
$97.62 - $132.29 $238,778 - $323,581
-2,446 Reduced 4.13%
56,825 $7.5 Million
Q4 2018

Feb 11, 2019

BUY
$94.85 - $109.54 $108,982 - $125,861
1,149 Added 1.98%
59,271 $6.11 Million
Q3 2018

Nov 14, 2018

SELL
$98.13 - $108.9 $90,279 - $100,188
-920 Reduced 1.56%
58,122 $6.32 Million
Q2 2018

Jul 27, 2018

SELL
$96.1 - $103.24 $39,785 - $42,741
-414 Reduced 0.7%
59,042 $5.83 Million
Q1 2018

May 08, 2018

SELL
$92.16 - $103.8 $290,856 - $327,592
-3,156 Reduced 5.04%
59,456 $5.82 Million
Q4 2017

Feb 07, 2018

BUY
$85.26 - $94.62 $11,169 - $12,395
131 Added 0.21%
62,612 $5.81 Million
Q3 2017

Nov 09, 2017

BUY
$79.29 - $88.45 $381,305 - $425,356
4,809 Added 8.34%
62,481 $5.36 Million
Q2 2017

Aug 10, 2017

BUY
N/A
57,672
57,672 $4.87 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $165B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Jacobson & Schmitt Advisors, LLC Portfolio

Follow Jacobson & Schmitt Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobson & Schmitt Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jacobson & Schmitt Advisors, LLC with notifications on news.